Marc Arbyn - Epidemiology

Author Information

Marc Arbyn is a distinguished researcher affiliated with the Unit of Cancer Epidemiology at the Belgian Cancer Centre, Sciensano, located in Brussels, Belgium. His work primarily focuses on cancer epidemiology, with a particular emphasis on cervical cancer screening and human papillomavirus (HPV) research.

Research Contributions

Marc Arbyn has made significant contributions to the field of cancer epidemiology, particularly in the area of cervical cancer screening and HPV testing. In 2022 alone, he has authored multiple influential papers on topics ranging from the clinical accuracy of HPV self-sampling to the performance of HPV assays and meta-analyses on diagnostic test accuracy. His work has been instrumental in shaping international consensus on cancer screening programs and developing protocols for the validation of diagnostic assays.

Aliases

Marc Arbyn is also known by several aliases including M Arbyn, M. Arbyn, and Mark Arbyn.

Publication and Citation Metrics

Metric	Value
Total Citations	30,910
H-Index	77
Number of Papers	410

Publications:

HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer

DOI: 10.1016/j.lanepe.2022.100332

Year: 2022

The IARC Perspective on Cervical Cancer Screening

DOI: 10.1097/ogx.0000000000001017

Year: 2022

Reply to: Comments on 'Meta-analysis of agreement/concordance statistics in studies comparing self- versus clinician-collected samples for HPV testing in cervical cancer screening'.

DOI: 10.1002/ijc.34013

Year: 2022

Meta-analysis of agreement/concordance statistics in studies comparing self- versus clinician-collected samples for HPV testing in cervical cancer screening.

DOI: 10.1002/ijc.33967

Year: 2022

Clinical performance of the full genotyping Agena MassARRAY HPV assay using SurePath screening samples within the VALGENT4 framework.

DOI: 10.1016/j.jmoldx.2021.12.009

Year: 2022

Metadta: a Stata command for meta-analysis and meta-regression of diagnostic test accuracy data – a tutorial

DOI: 10.1186/s13690-021-00747-5

Year: 2022

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study

DOI: 10.1136/bmj-2021-068582

Year: 2022

An international consensus on the essential and desirable criteria for an ‘organized’ cancer screening programme

DOI: 10.1186/s12916-022-02291-7

Year: 2022

Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening

DOI: 10.3389/ijph.2022.1604284

Year: 2022

VALCOR: a protocol for the validation of SARS-corona virus-2 assays

DOI: 10.1186/s13690-022-00869-4

Year: 2022

Why is There Pressure to Publish?

Why are Relationships Important?

Who Should Get a Mammogram?

What is Donning?

What is the Temporal Dimension?

What are the determinants of health in pregnancy?

Why are Airflow Patterns Important in Epidemiology?

How Did Snow Collect Data?

What are Geospatial Maps?

Why Are Direct Costs Important?

Partnered Content Networks

Relevant Topics